FDA Archives - Page 51 of 220

2 minute read

FDA Approves Verrica Pharma’s Ycanth: First Treatment Of Molluscum Contagiosum Impacting 6M People In US

July 24, 8:19 AM

The FDA approved Verrica Pharmaceuticals Inc's (NASDAQ: VRCA) Ycanth (cantharidin) topical solution for molluscum contagiosum (molluscum) in adult and pediatric patients

VRCA

2 minute read

Horizon Therapeutics Announces Phase 2 Trial Evaluating Daxdilimab For The Treatment Of Systemic Lupus Erythematosus Did Not Meet Primary Endpoint

By Happy Mohamed

July 21, 4:31 PM

- The Company continues to assess the full dataset; daxdilimab trials in alopecia areata, discoid lupus erythematosus and lupus nephritis ongoing – Horizon Therapeutics plc (NASDAQ:HZNP) today announced that

HZNP

5 minute read

BD Receives FDA 510(k) Clearance For Updated BD Alaris Infusion System

By Happy Mohamed

July 21, 4:30 PM

BD Alaris™ Infusion System is the only modular and most comprehensive infusion system on the U.S. market that includes large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory

BDX

3 minute read

Verrica Pharmaceuticals Announces FDA Approval Of YCANTH Topical Solution As The First FDA Approved Treatment Of Pediatric And Adult Patients With Molluscum Contagiosum

By Happy Mohamed

July 21, 4:26 PM

– Molluscum, is a highly contagious viral skin infection affecting approximately 6 million people annually in the United States, primarily children – – YCANTH™ is a drug-device combination

VRCA

3 minute read

FDA, Get It Done! Says Senator In Bipartisan Push To Regulate CBD Products Prior To Committee Hearing

By Nina Zdinjak

July 21, 10:35 AM

A bipartisan group of U.S. lawmakers reintroduced a measure on Wednesday that aims to secure the Food and Drug Administration’s (FDA)…

JAZZ

1 minute read

FDA Greenlights Daiichi Sankyo’s Blood Cancer Drug, A Promising Competitor to Novartis’ Rydapt

By Vandana Singh

July 21, 9:44 AM

The FDA has approved Daiichi Sankyo's (OTC: DSNKY) Vanflyta (quizartinib) in

ALMPY

3 minute read

Incannex Submits IND Application To The U.S. FDA For IHL-42X For Obstructive Sleep Apnoea

By Happy Mohamed

July 21, 9:10 AM

Incannex Healthcare Limited (NASDAQ:IXHL) (ASX: IHL), (‘Incannex' or the ‘Company') a clinical-stage pharmaceutical company developing unique medicinal cannabinoid pharmaceutical products and

IXHL

1 minute read

Emergent BioSolutions’ Two-Dose Anthrax Vaccine Secures FDA Nod; Shares Jump

By Vandana Singh

July 21, 6:15 AM

The FDA approved Emergent BioSolutions Inc's (NYSE: EBS) anthrax vaccine for adults

EBS

1 minute read

What’s Going On With T2 Biosystems Shares Today?

By Adam Eckert

July 20, 9:59 AM

T2 Biosystems Inc (NASDAQ: TTOO) shares are trading higher Thursday after the FDA granted Breakthrough Device designation for the company's Candida auris

TTOO

2 minute read

Juul’s Next-Generation Vaporizer Seeks FDA Approval Amid Market Uncertainty

By Vandana Singh

July 20, 8:16 AM

The e-cigarette maker, Juul Labs Inc, seeks FDA approval for its next-generation vaporizer, already available in the U.K. and Canada. The company is a word on whether its current products can stay on the market.